متابعة
Anubhav Kaviratna
Anubhav Kaviratna
بريد إلكتروني تم التحقق منه على fda.hhs.gov
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth–Throat Models and In Vitro—In Vivo Correlations for a Dry Powder Inhaler, Metered …
X Wei, M Hindle, A Kaviratna, BK Huynh, RR Delvadia, D Sandell, ...
Journal of aerosol medicine and pulmonary drug delivery 31 (6), 358-371, 2018
812018
Delivery and performance of surfactant replacement therapies to treat pulmonary disorders
N El-Gendy, A Kaviratna, C Berkland, P Dhar
Therapeutic Delivery 4 (8), 951-980, 2013
522013
Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth
RL Walenga, PW Longest, A Kaviratna, M Hindle
Journal of Aerosol Medicine and Pulmonary Drug Delivery 30 (3), 190-205, 2017
302017
Evaluation of bio-relevant mouth-throat models for characterization of metered dose inhalers
A Kaviratna, G Tian, X Liu, R Delvadia, S Lee, C Guo
AAPS PharmSciTech 20, 1-9, 2019
282019
Dynamic measurements of membrane insertion potential of synthetic cell penetrating peptides
NA Alhakamy, A Kaviratna, CJ Berkland, P Dhar
Langmuir 29 (49), 15336-15349, 2013
282013
Proapoptotic lipid nanovesicles: Synergism with paclitaxel in human lung adenocarcinoma A549 cells
N Joshi, T Shanmugam, A Kaviratna, R Banerjee
Journal of controlled release 156 (3), 413-420, 2011
282011
The effect of acids on dipalmitoyl phosphatidylcholine (DPPC) monolayers and liposomes
AS Kaviratna, R Banerjee
Colloids and Surfaces A: Physicochemical and Engineering Aspects 345 (1-3 …, 2009
282009
Nanovesicle aerosols as surfactant therapy in lung injury
AS Kaviratna, R Banerjee
Nanomedicine: Nanotechnology, Biology and Medicine 8 (5), 665-672, 2012
222012
Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective
B Newman
Advanced Drug Delivery Reviews 190, 114526, 2022
182022
Aerosol delivery of paclitaxel-containing self-assembled nanocochleates for treating pulmonary metastasis: An approach supporting pulmonary mechanics
T Shanmugam, N Joshi, A Kaviratna, N Ahamad, E Bhatia, R Banerjee
ACS Biomaterials Science & Engineering 7 (1), 144-156, 2020
162020
Multi trigger responsive, surface active lipid nanovesicle aerosols for improved efficacy of paclitaxel in lung cancer
N Joshi, A Kaviratna, R Banerjee
Integrative Biology 5 (1), 239-248, 2013
142013
Advancements in the design and development of dry powder inhalers and potential implications for generic development
AR Mohan, Q Wang, S Dhapare, E Bielski, A Kaviratna, L Han, S Boc, ...
Pharmaceutics 14 (11), 2495, 2022
132022
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective
N El-Gendy
Advanced Drug Delivery Reviews 189, 114519, 2022
122022
Effect of meconium on surface properties of surfactant monolayers and liposomes
V Pallem, AS Kaviratna, G Chimote, R Banerjee
Colloids and Surfaces A: Physicochemical and Engineering Aspects 370 (1-3), 6-14, 2010
92010
Pulmonary Surfactant Nanostructures and their Implications
A Kaviratna, A Shah, SS Rao, R Banerjee
Dynamic Biochemistry, Process Biotechnology and Molecular Biology 3 (2), 21-32, 2009
42009
In vitro evaluation of intersubject variability in pediatric intranasal drug delivery using nasal spray suspension products
AR Esmaeili, JV Wilkins, S Hosseini, A Alfaifi, M Hejazi, M Hindle, ...
Journal of Aerosol Science 179, 106387, 2024
32024
Protein free surfactant composition for pulmonary diseases and a process for preparing the same
R Banerjee, A Kaviratna
US Patent 9,345,716, 2016
32016
Characterization of spray dried azithromycin dry powders for inhalation
M Hindle, A Kaviratna, D Yamarthi, P Longest
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 28 (4), A9-A9, 2015
32015
CFD-PK model for nasal suspension sprays: Validation with human adult in vivo data for triamcinolone acetonide
R Dutta, AV Kolanjiyil, RL Walenga, SG Chopski, A Kaviratna, AR Mohan, ...
International Journal of Pharmaceutics 665, 124660, 2024
22024
Anatomically-detailed segmented representative adult and pediatric nasal models for assessing regional drug delivery and bioequivalence with suspension nasal sprays
P Khadka, M Hejazi, M Hindle, T Schuman, W Longest, A Kaviratna, ...
International Journal of Pharmaceutics 666, 124743, 2024
12024
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20